CreditReports.dk
HomeScreen companies

LEO PHARMA A/S Financials, key figures and credit report

CVR number: 56759514 Established 1962 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Industriparken 55, 2750 Ballerup
Net sales 13 499.0 mDKK FY 2025 +8.4% vs 2024
EBIT margin 16.9 % FY 2025 +26.1 pp vs 2024
Net debt 9 185.0 mDKK FY 2025 -14.7% vs 2024
Quick ratio 0.7 FY 2025 +0.1 vs 2024

Company information

Official name
LEO PHARMA A/S
Personnel
1053 persons
Established
1962
Company form
Limited company
Industry

Data sources and methodology

The information about LEO PHARMA A/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2025.

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About LEO PHARMA A/S

LEO PHARMA A/S (CVR number: 5675951-4) is a company from BALLERUP. The company reported a net sales of 13499 mDKK in 2025, demonstrating a growth of 8.4 % compared to the previous year. The operating profit percentage was at 16.9 % (EBIT: 2279 mDKK), while net earnings were 2489 mDKK. The profitability of the company measured by Return on Assets (ROA) was 11.8 %, which can be considered good but Return on Equity (ROE) was 62.5 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 25.7 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. LEO PHARMA A/S's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.

Financial information

See financials

Net sales (mDKK)

EBIT (mDKK)

Profitability

Solidity

Key figures (mDKK)

See financials
2021
2022
2023
2024
2025
Volume
Net sales9 957.0010 641.0011 392.0012 453.0013 499.00
Gross profit5 995.006 283.007 200.007 518.008 240.00
EBIT-4 156.00-3 311.00-1 699.00-1 143.002 279.00
Net earnings-4 868.00-4 110.00-3 607.00-1 776.002 489.00
Shareholders equity total5 537.001 946.004 525.002 704.005 262.00
Balance sheet total (assets)23 695.0022 932.0020 951.0020 151.0020 445.00
Net debt10 121.0013 972.0010 530.0010 764.009 185.00
Profitability
EBIT-%-41.7 %-31.1 %-14.9 %-9.2 %16.9 %
ROA-17.4 %-14.2 %-7.5 %-4.9 %11.8 %
ROE-78.0 %- 109.8 %- 111.5 %-49.1 %62.5 %
ROI-22.5 %-18.6 %-9.5 %-6.2 %15.1 %
Economic value added (EVA)-5 132.22-4 158.50-3 030.60-1 820.98917.55
Solvency
Equity ratio23.4 %8.5 %21.6 %13.4 %25.7 %
Gearing190.6 %731.9 %237.5 %406.5 %179.0 %
Relative net indebtedness %178.0 %194.7 %142.3 %138.3 %110.7 %
Liquidity
Quick ratio0.60.60.80.60.7
Current ratio1.21.41.81.51.4
Cash and cash equivalents432.00270.00216.00227.00235.00
Capital use efficiency
Trade debtors turnover (days)82.673.368.669.482.2
Net working capital %11.9 %21.9 %32.7 %22.1 %18.2 %

Variable visualization

ROA FY 2025
11.8%
Rating 61/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2025
25.7%
Rating 23/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of LEO PHARMA A/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
€3 / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated